← All stocks

CHEMED CORP

CHE Net selling

CIK 0000019584 #1119 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$1.62M

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$1.62M

2 of 2 sales

Net

−$1.62M

−$1.62M against sales at will

By person

14 insiders · 2 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

MCNAMARA KEVIN J

president and CEO

—

$1.08M (1)

−$1.08M

70,418

0.5388%

$38.11M

−34.6%

LEE SPENCER S

executive vice president

—

$541.04K (1)

−$541.04K

13,912

0.1064%

$7.53M

−30.5%

HUTTON THOMAS C

vice president

—

32,481

0.2485%

$17.58M

+1.2%

Witzeman Michael D

VP & Chief Financial Officer

—

5,953

0.0455%

$3.22M

+57.3%

LINDELL ANDREA R

Director

—

4,578

0.0350%

$2.48M

−20.0%

GRACE PATRICK P

Director

—

3,533

0.0270%

$1.91M

+8.0%

Judkins Brian C

VP and Chief Legal Officer

—

3,344

0.0256%

$1.81M

+118.1%

WALSH GEORGE J III

Director

—

3,209

0.0246%

$1.74M

−1.1%

Heaney Christopher J

Director

—

2,775

0.0212%

$1.50M

+31.4%

DeLyons Ron

Director

—

2,052

0.0157%

$1.11M

+47.7%

Mount John Meredith Jr.

Director

—

1,316

0.0101%

$712.17K

+101.5%

McCarthy Eileen P

Director

—

1,241

0.0095%

$671.58K

+114.7%

Wherley Joel L

CEO - Vitas Healthcare

—

1,181

0.0090%

$639.11K

+79.2%

Westfall Nicholas Michael

Executive Vice President

—

0.0000%

$0.00

−100.0%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 2

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 2

Transactions with no price 0

Shares from compensation/vesting 0

History held since 23 Sep 2016